The Heterodimeric Assembly of the CD94-NKG2 Receptor Family and Implications for Human Leukocyte Antigen-E Recognition

Immunity

Volumn 27, Issue 6, 2007, Pages 900-911

  Sullivan, Lucy C ^a   Clements, Craig S ^b   Beddoe, Travis ^b   Johnson, Darryl ^a   Hoare, Hilary L ^b   Lin, Jie ^a   Huyton, Trevor ^b   Hopkins, Emma J ^b   Reid, Hugh H ^b   Wilce, Matthew C J ^b   Kabat, Juraj ^c   Borrego, Francisco ^c   Coligan, John E ^c   Rossjohn, Jamie ^b   Brooks, Andrew G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Australian Government Australian Research Council   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

MOLIMMUNO

Indexed keywords

CD94 ANTIGEN; HETERODIMER; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; PROTEIN SUBUNIT;

ANTIGEN RECOGNITION; ARTICLE; CRYSTAL STRUCTURE; DIMERIZATION; MUTAGENESIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FAMILY; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, CD94; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN SUBUNITS; RECEPTORS, IMMUNOLOGIC;

EID: 37149026664     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.10.013     Document Type: Article

References (43)

1. + T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J. Immunol. 162 (1999) 3996-4002
2. Bland F.A., Lemberg M.K., McMichael A.J., Martoglio B., and Braud V.M. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J. Biol. Chem. 278 (2003) 33747-33752
3. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., and Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187 (1998) 813-818
4. Borrego F., Masilamani M., Marusina A.I., Tang X., and Coligan J.E. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol. Res. 35 (2006) 263-278
5. Boyington J.C., Riaz A.N., Patamawenu A., Coligan J.E., Brooks A.G., and Sun P.D. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity 10 (1999) 75-82
6. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 (2000) 537-543
7. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
8. Braud V.M., Allan D.S., Wilson D., and McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8 (1998) 1-10
9. Brooks A.G., Posch P.E., Scorzelli C.J., Borrego F., and Coligan J.E. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185 (1997) 795-800
10. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., Weiss E.H., and Coligan J.E. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162 (1999) 305-313
11. Brostjan C., Bellon T., Sobanov Y., Lopez-Botet M., and Hofer E. Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones. J. Immunol. Methods 264 (2002) 109-119
12. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
13. Carretero M., Cantoni C., Bellon T., Bottino C., Biassoni R., Rodriguez A., Perez-Villar J.J., Moretta L., Moretta A., and Lopez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27 (1997) 563-567
14. Cella M., Nakajima H., Facchetti F., Hoffmann T., and Colonna M. ILT receptors at the interface between lymphoid and myeloid cells. Curr. Top. Microbiol. Immunol. 251 (2000) 161-166
15. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
16. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
17. Hoare H.L., Sullivan L.C., Pietra G., Clements C.S., Lee E.J., Ely L.K., Beddoe T., Falco M., Kjer-Nielsen L., Reid H.H., et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7 (2006) 256-264
18. Houchins J.P., Yabe T., McSherry C., and Bach F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173 (1991) 1017-1020
19. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., and Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158 (1997) 3603-3609
20. Kaiser B.K., Barahmand-Pour F., Paulsene W., Medley S., Geraghty D.E., and Strong R.K. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174 (2005) 2878-2884
21. Kim D.K., Kabat J., Borrego F., Sanni T.B., You C.H., and Coligan J.E. Human NKG2F is expressed and can associate with DAP12. Mol. Immunol. 41 (2004) 53-62
22. Kogelberg H., and Feizi T. New structural insights into lectin-type proteins of the immune system. Curr. Opin. Struct. Biol. 11 (2001) 635-643
23. Lanier L.L., Corliss B., Wu J., and Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8 (1998) 693-701
24. Lazetic S., Chang C., Houchins J.P., Lanier L.L., and Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157 (1996) 4741-4745
25. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., and Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95 (1998) 5199-5204
26. Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., and Strong R.K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2 (2001) 443-451
27. Li P., McDermott G., and Strong R.K. Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity 16 (2002) 77-86
28. Lieto L.D., Maasho K., West D., Borrego F., and Coligan J.E. The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B. Genes Immun. 7 (2006) 36-43
29. Llano M., Lee N., Navarro F., Garcia P., Albar J.P., Geraghty D.E., and Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28 (1998) 2854-2863
30. Lodoen M.B., and Lanier L.L. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3 (2005) 59-69
31. McCoy A.J., Storoni L.C., Grosse-Kunstleve R.W., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61 (2005) 458-464
32. McFarland B.J., and Strong R.K. Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity 19 (2003) 803-812
33. McFarland B.J., Kortemme T., Yu S.F., Baker D., and Strong R.K. Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure 11 (2003) 411-422
34. Miller J.D., Weber D.A., Ibegbu C., Pohl J., Altman J.D., and Jensen P.E. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171 (2003) 1369-1375
35. Natarajan K., Sawicki M.W., Margulies D.H., and Mariuzza R.A. Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells. Biochemistry 39 (2000) 14779-14786
36. Sawicki M.W., Dimasi N., Natarajan K., Wang J., Margulies D.H., and Mariuzza R.A. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol. Rev. 181 (2001) 52-65
37. Tormo J., Natarajan K., Margulies D.H., and Mariuzza R.A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402 (1999) 623-631
38. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., and Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18 (1999) 4250-4260
39. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., and Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188 (1998) 1841-1848
40. Vance R.E., Jamieson A.M., and Raulet D.H. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190 (1999) 1801-1812
41. Wada H., Matsumoto N., Maenaka K., Suzuki K., and Yamamoto K. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur. J. Immunol. 34 (2004) 81-90
42. Wolan D.W., Teyton L., Rudolph M.G., Villmow B., Bauer S., Busch D.H., and Wilson I.A. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat. Immunol. 2 (2001) 248-254
43. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., and Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 (1999) 730-732